| 1. |
- Kimberling, W. J., et al.
(author)
-
Linkage of Usher syndrome type I gene (USH1B) to the long arm of chromosome 11
- 1992
-
In: Genomics. - 0888-7543 .- 1089-8646. ; 14:4, s. 988-994
-
Journal article (peer-reviewed)abstract
- Usher syndrome is the most commonly recognized cause of combined visual and hearing loss in technologically developed countries. There are several different types and all are inherited in an autosomal recessive manner. There may be as many as five different genes responsible for at least two closely related phenotypes. The nature of the gene defects is unknown, and positional cloning strategies are being employed to identify the genes. This is a report of the localization of one gene for Usher syndrome type I to chromosome 11q, probably distal to marker D11S527. Another USH1 gene had been previously localized to chromosome 14q, and this second localization establishes the existence of a new and independent locus for Usher syndrome.
|
|
| 2. |
- Kimberling, W. J., et al.
(author)
-
Genetic studies of Usher syndrome
- 1991
-
In: Annals of the New York Academy of Sciences. - : Wiley. - 0077-8923 .- 1749-6632. ; 630:1, s. 167-175
-
Journal article (peer-reviewed)
|
|
| 3. |
|
|
| 4. |
- Olsson, H., et al.
(author)
-
Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.
- 1991
-
In: Cancer Detection and Prevention. - 0361-090X. ; 15:4, s. 265-271
-
Journal article (peer-reviewed)abstract
- In southern Sweden, extensive oral contraceptive use (OC use) among young women was a reality during the 1960s, thus making our region especially suited for studies investigating the hypothesis that early OC use is associated with the development of premenopausal breast cancer after a possible latency time between the exposure and the disease. The results of this study revealed that the risk of developing premenopausal breast cancer in women, who during the 1960s used the pill as teenagers, is five times greater than nonusers. The risk for early users is further modified by the duration of use at an early age, implying a dose-response relationship. Later use of OCs is not associated with an increased risk for the disease. Women with breast cancer, who at an early age have used the pill, have larger breast tumors, lower estrogen receptor concentrations of their primary tumor, and a worse prognosis compared with later and nonusers with breast cancer. The incidence of breast cancer in Sweden rapidly increased in women 25 to 40 years of age between 1970 and 1984. Conventional risk factors or a change in diagnostic activities of breast cancer cannot explain the increase in incidence which could be due to the OC exposure. Studies on the risk with modern OCs must wait another 20 years because of a too short latency time.
|
|
